GNOM vs. TMQ
Compare and contrast key facts about Global X Genomics & Biotechnology ETF (GNOM) and Trilogy Metals Inc. (TMQ).
GNOM is a passively managed fund by Global X that tracks the performance of the Solactive Genomics Index. It was launched on Apr 5, 2019.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: GNOM or TMQ.
Key characteristics
| GNOM | TMQ | |
|---|---|---|
| YTD Return | -13.26% | -2.40% |
| 1Y Return | -19.53% | -30.02% |
| 3Y Return (Ann) | -23.99% | -43.20% |
| 5Y Return (Ann) | -7.11% | -30.89% |
| Sharpe Ratio | -0.69 | -0.47 |
| Daily Std Dev | 29.15% | 55.71% |
| Max Drawdown | -68.54% | -96.55% |
| Current Drawdown | -64.04% | -91.11% |
Correlation
The correlation between GNOM and TMQ is 0.24, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
GNOM vs. TMQ - Performance Comparison
In the year-to-date period, GNOM achieves a -13.26% return, which is significantly lower than TMQ's -2.40% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
GNOM vs. TMQ - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Global X Genomics & Biotechnology ETF (GNOM) and Trilogy Metals Inc. (TMQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
GNOM vs. TMQ - Dividend Comparison
Neither GNOM nor TMQ has paid dividends to shareholders.
| TTM | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|
GNOM Global X Genomics & Biotechnology ETF | 0.00% | 0.00% | 0.00% | 0.03% | 0.14% |
TMQ Trilogy Metals Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
GNOM vs. TMQ - Drawdown Comparison
The maximum GNOM drawdown since its inception was -68.54%, smaller than the maximum TMQ drawdown of -96.55%. Use the drawdown chart below to compare losses from any high point for GNOM and TMQ. For additional features, visit the drawdowns tool.
Volatility
GNOM vs. TMQ - Volatility Comparison
The current volatility for Global X Genomics & Biotechnology ETF (GNOM) is 8.32%, while Trilogy Metals Inc. (TMQ) has a volatility of 28.79%. This indicates that GNOM experiences smaller price fluctuations and is considered to be less risky than TMQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.